Mechanobiology of Type 1 Hypersensitivity: Elucidating the Impacts of Mechanical Forces in Allergic Reactions

Type 1 hypersensitivity involves an exaggerated immune reaction triggered by allergen exposure, leading to rapid release of inflammatory mediators. Meanwhile, mechanobiology explores how physical forces influence cellular processes, and recent research underscores its relevance in allergic reactions. This review provides a concise overview of Type 1 hypersensitivity, highlighting the pivotal role of mast cells and immunoglobulin E (IgE) antibodies in orchestrating allergic reactions. Recognizing the dynamic nature of cellular responses in allergies, this study subsequently delves into the emerging field of mechanobiology and its significance in understanding the mechanical forces governing immune cell behavior. Furthermore, molecular forces during mast cell activation and degranulation are explored, elucidating the mechanical aspects of IgE binding and cytoskeletal rearrangements. Next, we discuss the intricate interplay between immune cells and the extracellular matrix, emphasizing the impact of matrix stiffness on cellular responses. Additionally, we examine key mechanosensitive signaling pathways, including the mitogen-activated protein kinase (MAPK) pathway, Rho guanosine triphosphatase (GTPase) and integrin-mediated focal adhesion signaling, shedding light on their contributions to hypersensitivity reactions. This interplay of mechanobiology and Type 1 hypersensitivity provides insights into potential therapeutic targets and biomarkers, paving the way for better clinical management of Type 1 hypersensitivity reactions.Keywords: Type 1 hypersensitivity; mechanobiology; mechanosensing; mechanotransduction; allergy.IntroductionType 1 hypersensitivity represents a prototypical allergic reaction characterized by an exaggerated immune response to innocuous substances, known as allergens. This hypersensitivity is classified as an immediate or immunoglobulin E (IgE)-mediated hypersensitivity, involving the immediate release of inflammatory mediators upon re-exposure to specific allergens. The sensitization phase begins when the immune system of individuals prone to Type 1 hypersensitivity responds to the first exposure of specific allergens by producing IgE antibodies [1,2]. These IgE antibodies occupy the high-affinity IgE receptors on the surface of mast cells and basophils. Upon subsequent exposure to these specific allergens, the crosslink between allergens and IgE antibodies activate mast cells and basophils, triggering the release of potent mediators such as histamine, leukotrienes, and cytokines (Figure 1 ) [1,3–5]. The rapid release of these mediators results in the clinical manifestations of allergy, ranging from mild symptoms like itching and sneezing to severe, life-threatening reactions like anaphylaxis [1,6]. Common allergens implicated in Type 1 hypersensitivity span a broad spectrum, including environmental allergens such as pollen, dust mites and animal dander, as well as food allergens like nuts, shellfish and eggs. Additionally, insect venom, certain medications and latex are recognized triggers [7]. The role of allergens in Type 1 hypersensitivity is pivotal, as the immune system perceives them as foreign and mounts an immune response, with subsequent exposures leading to heightened sensitivity and escalating allergic reactions [8].